FDA released its long-anticipated Communications with Payer Guidance in late 2018. “With rising healthcare costs, it's ever more important for payers to make the right informed decisions about access. From an industry perspective, we have to help them think about the value of the products,” suggests Sissi Pham, Founder and CEO of AESARA, Inc. and the AESARA Foundation. “This new guidance is actually a win for industry, but also a win for payers because now the channel of communication is open.”